DZ3155A1 - Nouvelle composition pharmaceutique. - Google Patents

Nouvelle composition pharmaceutique.

Info

Publication number: DZ3155A1
Authority: DZ; Algeria
Prior art keywords: pharmaceutical composition; new pharmaceutical; new; composition; pharmaceutical
Prior art date: 1999-04-23

Application number

DZ003155A

Other languages

English (en)

Inventor

Paul David James Blackler

Robert Gordon Cilles

Michael John Sasse

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2000-04-19

Publication date

2000-11-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315460&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ3155(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-04-23 Priority claimed from GBGB9909472.4A external-priority patent/GB9909472D0/en

1999-05-25 Priority claimed from GBGB9912197.2A external-priority patent/GB9912197D0/en

2000-04-19 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-11-02 Application granted granted Critical

2000-11-02 Publication of DZ3155A1 publication Critical patent/DZ3155A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

DZ003155A 1999-04-23 2000-04-19 Nouvelle composition pharmaceutique. DZ3155A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9909472.4A GB9909472D0 (en)	1999-04-23	1999-04-23	Novel compounds
GBGB9912197.2A GB9912197D0 (en)	1999-05-25	1999-05-25	Novel pharmaceutical
PCT/GB2000/001514 WO2000064892A2 (fr)	1999-04-23	2000-04-19	Nouvelle composition pharmaceutique

Publications (1)

Publication Number	Publication Date
DZ3155A1 true DZ3155A1 (fr)	2000-11-02

Family

ID=26315460

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ003155A DZ3155A1 (fr)	1999-04-23	2000-04-19	Nouvelle composition pharmaceutique.

Country Status (40)

Country	Link
US (2)	US6815457B1 (fr)
EP (3)	EP1284268B1 (fr)
JP (1)	JP2002543075A (fr)
KR (1)	KR100744359B1 (fr)
CN (1)	CN1208335C (fr)
AP (1)	AP1495A (fr)
AR (2)	AR023568A1 (fr)
AT (2)	ATE247653T1 (fr)
AU (1)	AU765498B2 (fr)
BG (1)	BG65427B1 (fr)
BR (1)	BR0009934A (fr)
CA (1)	CA2370258A1 (fr)
CO (1)	CO5170424A1 (fr)
CY (1)	CY1107238T1 (fr)
CZ (1)	CZ20013799A3 (fr)
DE (2)	DE60037602T2 (fr)
DK (2)	DK1284268T3 (fr)
DZ (1)	DZ3155A1 (fr)
EA (1)	EA004534B1 (fr)
ES (2)	ES2204557T3 (fr)
HK (1)	HK1045154B (fr)
HR (1)	HRP20010773B1 (fr)
HU (1)	HUP0200929A3 (fr)
IL (1)	IL146110A0 (fr)
MA (1)	MA26785A1 (fr)
MX (1)	MXPA01010820A (fr)
MY (1)	MY128007A (fr)
NO (1)	NO320589B1 (fr)
NZ (1)	NZ515163A (fr)
OA (1)	OA11871A (fr)
PE (1)	PE20010040A1 (fr)
PL (1)	PL351686A1 (fr)
PT (2)	PT1173434E (fr)
RS (1)	RS50114B (fr)
SK (1)	SK286423B6 (fr)
TR (1)	TR200103061T2 (fr)
TW (1)	TW591027B (fr)
UA (1)	UA67843C2 (fr)
UY (1)	UY26120A1 (fr)
WO (1)	WO2000064892A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726568D0 (en)	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US6664278B2 (en)	1997-12-16	2003-12-16	Smithkline Beecham P.L.C.	Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US20020137940A1 (en) *	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
CO5170421A1 (es)	1999-04-23	2002-06-27	Smithkline Beecham Plc	Nuevo compuesto farmaceutico maleico
IL146110A0 (en)	1999-04-23	2002-07-25	Smithkline Beecham Plc	Thiazolidinedione derivative and its use as antidiabetic
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0006133D0 (en)	2000-03-14	2000-05-03	Smithkline Beecham Plc	Novel pharmaceutical
US7241895B2 (en) *	2000-09-26	2007-07-10	Dr. Reddy's Laboratories Limited	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
MXPA03002580A (es) *	2000-09-26	2003-10-15	Cord Janet I	Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
WO2003050116A1 (fr) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Sel d'acide 10-camphorsulphonique de 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione et son utilisation contre le diabete sucre
WO2003053962A1 (fr) *	2001-12-20	2003-07-03	Smithkline Beecham Plc	Sel d'acide malique 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy) benzyl) thiazolidine-2, 4-dione et son utilisation contre le diabete sucre
GB0130511D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0307259D0 (en) *	2003-03-28	2003-05-07	Glaxo Group Ltd	Process
EP1468997A3 (fr) *	2003-04-18	2004-11-03	CHEMI S.p.A.	Formes polymorphes de maléate de rosiglitatone
GB2405403A (en) *	2003-08-29	2005-03-02	Cipla Ltd	Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (fr) *	2004-01-28	2006-10-11	Usv Limited	Procede de preparation de maleate de 5- 4- 2- n-methyl-n-(2-pyridyl) amino¨ ethoxy¨ phenyl methyl¨ thiazolidine-2, 4-dione
ITMI20041537A1 (it) *	2004-07-28	2004-10-28	Chemi Spa	Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) *	2005-05-24	2007-09-26	Zentiva, A. S.	Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
US20090076093A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched rosiglitazone
EP2184055A1 (fr)	2008-11-07	2010-05-12	LEK Pharmaceuticals d.d.	Procédé de préparation de formes galéniques solides de maléate de rosiglitazone

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6288095B1 (en)	1987-09-04	2001-09-11	Beecham Group P.L.C.	Compounds
EP0306228B1 (fr)	1987-09-04	1999-11-17	Beecham Group Plc	Thiazolidinediones substituées
GB9124513D0 (en)	1991-11-19	1992-01-08	Smithkline Beecham Plc	Novel process
US5741803A (en)	1992-09-05	1998-04-21	Smithkline Beecham Plc	Substituted thiazolidinedionle derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
US5478852C1 (en) *	1993-09-15	2001-03-13	Sankyo Co	Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
CN1083715C (zh)	1994-02-10	2002-05-01	史密丝克莱恩比彻姆有限公司	胰岛素敏化物治疗肾病的应用
DE4404198A1 (de)	1994-02-10	1995-08-17	Henkel Kgaa	2-Fluor-6-nitroaniline
US20010044458A1 (en) *	1994-02-10	2001-11-22	Smithkline Beechamp P.L.C.	Use of insulin sensitisers for treating renal diseases
TWI238064B (en) *	1995-06-20	2005-08-21	Takeda Chemical Industries Ltd	A pharmaceutical composition for prophylaxis and treatment of diabetes
US6153632A (en) *	1997-02-24	2000-11-28	Rieveley; Robert B.	Method and composition for the treatment of diabetes
GB9711683D0 (en)	1997-06-05	1997-08-06	Smithkline Beecham Plc	Composition
NZ501163A (en)	1997-06-18	2002-02-01	Smithkline Beecham P	Treatment of diabetes with thiazolidinedione and sulphonylurea (glibenclamide, glipizide, gliclazide, glimepiride, tolazamide and tolbutamide
US20020004515A1 (en) *	1997-06-18	2002-01-10	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and metformin
GB9712866D0 (en)	1997-06-18	1997-08-20	Smithkline Beecham Plc	Novel method of treatment
US20010049380A1 (en) *	1997-06-18	2001-12-06	Smith Stephen Alistair	Treatment of diabetes with thiazolidinedione and sulphonylurea
AP1279A (en)	1997-06-18	2004-05-20	Smithkline Beecham Plc	Treatment of diabetes with thiazolidinedione and metformin.
US20020028768A1 (en) *	1997-06-18	2002-03-07	Smithkline Beecham P.L.C.	Treatment of diabetes with rosiglitazone and insulin
CN1274282A (zh)	1997-06-18	2000-11-22	史密丝克莱恩比彻姆有限公司	用噻唑烷二酮和α－葡糖苷酶抑制剂治疗糖尿病
US20020045649A1 (en) *	1997-07-18	2002-04-18	Smithkline Beecham P.L.C.	Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020016287A1 (en) *	1997-07-18	2002-02-07	Smithkline Beecham P.L.C.	Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9726566D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
US20020137940A1 (en)	1997-12-16	2002-09-26	Smithkline Beecham P.L.C.	5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726563D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
GB9726568D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Novel pharmaceutical
AP1607A (en)	1999-04-23	2006-05-03	Smithkline Beecham Plc	Thiazolidinedione derivative and its use as antidiabetic.
IL146110A0 (en)	1999-04-23	2002-07-25	Smithkline Beecham Plc	Thiazolidinedione derivative and its use as antidiabetic
CO5170421A1 (es)	1999-04-23	2002-06-27	Smithkline Beecham Plc	Nuevo compuesto farmaceutico maleico
MXPA03002580A (es)	2000-09-26	2003-10-15	Cord Janet I	Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.

2000
- 2000-04-19 IL IL14611000A patent/IL146110A0/xx unknown
- 2000-04-19 EP EP02080320A patent/EP1284268B1/fr not_active Expired - Lifetime
- 2000-04-19 HU HU0200929A patent/HUP0200929A3/hu not_active IP Right Cessation
- 2000-04-19 US US10/030,323 patent/US6815457B1/en not_active Expired - Fee Related
- 2000-04-19 CA CA002370258A patent/CA2370258A1/fr not_active Abandoned
- 2000-04-19 PT PT00920889T patent/PT1173434E/pt unknown
- 2000-04-19 PL PL00351686A patent/PL351686A1/xx not_active Application Discontinuation
- 2000-04-19 HR HR20010773A patent/HRP20010773B1/xx not_active IP Right Cessation
- 2000-04-19 EP EP07150378A patent/EP1903043A1/fr not_active Withdrawn
- 2000-04-19 PT PT02080320T patent/PT1284268E/pt unknown
- 2000-04-19 EP EP00920889A patent/EP1173434B1/fr not_active Expired - Lifetime
- 2000-04-19 DZ DZ003155A patent/DZ3155A1/fr active
- 2000-04-19 DK DK02080320T patent/DK1284268T3/da active
- 2000-04-19 RS YUP-752/01A patent/RS50114B/sr unknown
- 2000-04-19 EA EA200101119A patent/EA004534B1/ru not_active IP Right Cessation
- 2000-04-19 MX MXPA01010820A patent/MXPA01010820A/es unknown
- 2000-04-19 ES ES00920889T patent/ES2204557T3/es not_active Expired - Lifetime
- 2000-04-19 AR ARP000101870A patent/AR023568A1/es unknown
- 2000-04-19 CO CO00028932A patent/CO5170424A1/es not_active Application Discontinuation
- 2000-04-19 AP APAP/P/2001/002333A patent/AP1495A/en active
- 2000-04-19 CN CNB008090572A patent/CN1208335C/zh not_active Expired - Fee Related
- 2000-04-19 AT AT00920889T patent/ATE247653T1/de not_active IP Right Cessation
- 2000-04-19 AU AU41306/00A patent/AU765498B2/en not_active Ceased
- 2000-04-19 DE DE60037602T patent/DE60037602T2/de not_active Expired - Fee Related
- 2000-04-19 NZ NZ515163A patent/NZ515163A/xx unknown
- 2000-04-19 DK DK00920889T patent/DK1173434T3/da active
- 2000-04-19 TR TR2001/03061T patent/TR200103061T2/xx unknown
- 2000-04-19 CZ CZ20013799A patent/CZ20013799A3/cs unknown
- 2000-04-19 OA OA1200100275A patent/OA11871A/en unknown
- 2000-04-19 AT AT02080320T patent/ATE382046T1/de not_active IP Right Cessation
- 2000-04-19 HK HK02104882.1A patent/HK1045154B/en not_active IP Right Cessation
- 2000-04-19 ES ES02080320T patent/ES2298327T3/es not_active Expired - Lifetime
- 2000-04-19 WO PCT/GB2000/001514 patent/WO2000064892A2/fr not_active Ceased
- 2000-04-19 UA UA2001117938A patent/UA67843C2/uk unknown
- 2000-04-19 PE PE2000000364A patent/PE20010040A1/es not_active Application Discontinuation
- 2000-04-19 SK SK1491-2001A patent/SK286423B6/sk not_active IP Right Cessation
- 2000-04-19 KR KR1020017013557A patent/KR100744359B1/ko not_active Expired - Fee Related
- 2000-04-19 BR BR0009934-1A patent/BR0009934A/pt not_active Application Discontinuation
- 2000-04-19 DE DE60004658T patent/DE60004658T2/de not_active Expired - Fee Related
- 2000-04-19 AR ARP000101865A patent/AR023564A1/es unknown
- 2000-04-19 JP JP2000614244A patent/JP2002543075A/ja active Pending
- 2000-04-21 MY MYPI20001707A patent/MY128007A/en unknown
- 2000-04-24 UY UY26120A patent/UY26120A1/es not_active Application Discontinuation
- 2000-04-24 TW TW089107633A patent/TW591027B/zh not_active IP Right Cessation
2001
- 2001-10-22 NO NO20015149A patent/NO320589B1/no unknown
- 2001-10-22 MA MA26377A patent/MA26785A1/fr unknown
- 2001-11-20 BG BG106119A patent/BG65427B1/bg unknown
2003
- 2003-11-07 US US10/703,887 patent/US20040092555A1/en not_active Abandoned
2008
- 2008-03-12 CY CY20081100277T patent/CY1107238T1/el unknown

Also Published As

Publication number	Publication date
HRP20010773B1 (en)	2005-06-30
HK1045154A1 (en)	2002-11-15
RS50114B (sr)	2009-03-25
TR200103061T2 (tr)	2002-05-21
UA67843C2 (uk)	2004-07-15
NO20015149D0 (no)	2001-10-22
BR0009934A (pt)	2002-06-04
CO5170424A1 (es)	2002-06-27
MA26785A1 (fr)	2004-12-20
EA200101119A1 (ru)	2002-04-25
TW591027B (en)	2004-06-11
SK14912001A3 (sk)	2002-02-05
NO20015149L (no)	2001-12-17
US20040092555A1 (en)	2004-05-13
DK1173434T3 (da)	2003-12-08
BG106119A (en)	2002-05-31
ATE382046T1 (de)	2008-01-15
AR023564A1 (es)	2002-09-04
JP2002543075A (ja)	2002-12-17
MXPA01010820A (es)	2002-06-04
DE60004658T2 (de)	2004-06-24
EP1284268A1 (fr)	2003-02-19
HUP0200929A2 (en)	2002-08-28
ATE247653T1 (de)	2003-09-15
AR023568A1 (es)	2002-09-04
EP1284268B1 (fr)	2007-12-26
KR20020028873A (ko)	2002-04-17
CY1107238T1 (el)	2012-11-21
WO2000064892A2 (fr)	2000-11-02
DE60037602D1 (de)	2008-02-07
DE60037602T2 (de)	2009-01-08
PE20010040A1 (es)	2001-03-10
SK286423B6 (sk)	2008-09-05
ES2298327T3 (es)	2008-05-16
NO320589B1 (no)	2005-12-27
CN1208335C (zh)	2005-06-29
CN1355801A (zh)	2002-06-26
AU4130600A (en)	2000-11-10
PT1284268E (pt)	2008-03-10
MY128007A (en)	2007-01-31
WO2000064892A3 (fr)	2001-01-25
HK1045154B (en)	2004-06-25
EP1903043A1 (fr)	2008-03-26
CA2370258A1 (fr)	2000-11-02
ES2204557T3 (es)	2004-05-01
YU75201A (sh)	2004-09-03
HUP0200929A3 (en)	2004-03-29
EP1173434B1 (fr)	2003-08-20
IL146110A0 (en)	2002-07-25
HRP20010773A2 (en)	2002-10-31
AU765498B2 (en)	2003-09-18
HK1055293A1 (en)	2004-01-02
UY26120A1 (es)	2000-12-29
CZ20013799A3 (cs)	2002-04-17
DE60004658D1 (de)	2003-09-25
EP1173434A2 (fr)	2002-01-23
NZ515163A (en)	2004-02-27
BG65427B1 (bg)	2008-07-31
PT1173434E (pt)	2003-12-31
US6815457B1 (en)	2004-11-09
DK1284268T3 (da)	2008-04-28
OA11871A (en)	2006-03-27
EA004534B1 (ru)	2004-06-24
PL351686A1 (en)	2003-06-02
AP1495A (en)	2005-11-30
KR100744359B1 (ko)	2007-07-30

Publication	Publication Date	Title
MA26937A1 (fr)	2004-12-20	Nouvelle composition pharmaceutique.
FI991485L (fi)	2000-12-31	Uusi farmaseuttinen koostumus
DZ3155A1 (fr)	2000-11-02	Nouvelle composition pharmaceutique.
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
ID27415A (id)	2001-04-05	Komposisi farmaseutik
PT1242087E (pt)	2004-06-30	Composicoes farmaceuticas
TR199901077A3 (tr)	1999-12-21	Ispençiyari formülasyonlar.
FR2705566B1 (fr)	1996-04-05	Nouvelles compositions pharmaceutiques.
DZ2516A1 (fr)	2004-11-08	Composition pharmaceutique en aérosol.
MA26497A1 (fr)	2004-12-20	Nouvelle formulation pharmaceutique
ID29262A (id)	2001-08-16	Komposisi farmasi
TR199802624A3 (tr)	1999-10-21	Yeni farmasötik.
ID27201A (id)	2001-03-08	Komposisi farmasi
NO20014926L (no)	2001-12-13	Farmasöytiske forbindelser
DZ3164A1 (fr)	2000-11-02	Nouvel agent pharmaceutique.
PT1239832E (pt)	2004-10-29	Composicoes farmaceuticas
ID29294A (id)	2001-08-16	Komposisi farmasi
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
MA26531A1 (fr)	2004-12-20	Composition pharmaceutique
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
DZ3163A1 (fr)	2000-10-26	Nouvelle substance pharmaceutique.
FR2779145B1 (fr)	2004-07-30	Nouvelles compositions pharmaceutiques
ID25857A (id)	2000-11-09	Komposisi farmasi
DZ1965A1 (fr)	2002-07-17	Composition pharmaceutique nouvelle.